Literature DB >> 28615201

The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.

Xiaoxi Lin1, Rui Sun1, Fang Zhang1, Yuan Gao1, Lianghua Bin2, Ke Lan3.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV), which belongs to the Gammaherpesviridae, typically displays two different phases in its life cycle, the latent phase and the lytic phase. Latency-associated nuclear antigen (LANA), the primary viral product during latency, has been reported to bind to a series of cellular gene promoters to modulate gene transcription. To systemically elucidate the cellular genes regulated by LANA, we identified genome-wide LANA binding sites by chromatin immunoprecipitation coupled with sequencing (ChIP-seq). We stratified ChIP-seq data and found that LANA might be involved in the macromolecule catabolic process. Specifically, we found and verified that LANA could directly bind to the promoter of the SUMO/sentrin-specific peptidase 6 (SENP6) gene in vivo and in vitro LANA could repress SENP6 promoter activity in a dose-dependent manner in a reporter gene assay. LANA expression was sufficient to inhibit endogenous SENP6 expression at both the RNA and protein levels. Moreover, SENP6 overexpression in KSHV-infected cells reduced LANA at the protein level. Mechanistically, we found that SENP6 could interact with LANA and reduce the formation of sumoylated LANA, which relies on the desumoylation ability of SENP6. During de novo infection, SENP6 overexpression would decrease the abundance of LANA and enhance viral gene expression, which would hamper the establishment of latency. Taken together, these data suggest that KSHV-encoded LANA could inhibit SENP6 expression to regulate the abundance of itself, which may play an important role in controlling the establishment of latency.IMPORTANCE LANA, as a key latent protein produced by KSHV, is responsible for episome persistence and regulates viral reactivation. In the present study, our results demonstrated that LANA could bind to the promoter region of the SENP6 gene and inhibit SENP6 expression while the regulated SENP6 could in turn modulate the abundance of LANA through desumoylation. This delicate regulation may provide important insights to explain the abundance of LANA during KSHV latency.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  ChIP-seq; KSHV; Kaposi's sarcoma-associated herpesvirus; LANA; SENP6; sumoylation

Mesh:

Substances:

Year:  2017        PMID: 28615201      PMCID: PMC5553180          DOI: 10.1128/JVI.00806-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells.

Authors:  R N Shaw; J L Arbiser; M K Offermann
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

2.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

Review 3.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

4.  Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.

Authors:  Yi Jin; Zhiheng He; Deguang Liang; Quanzhi Zhang; Hongxing Zhang; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

5.  Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.

Authors:  Yoshihiro Izumiya; Thomas J Ellison; Edward T H Yeh; Jae U Jung; Paul A Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.

Authors:  Rajeev Kaul; Subhash C Verma; Erle S Robertson
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

7.  DNA-PK/Ku complex binds to latency-associated nuclear antigen and negatively regulates Kaposi's sarcoma-associated herpesvirus latent replication.

Authors:  Seho Cha; Chunghun Lim; Jae Young Lee; Yoon-Jae Song; Junsoo Park; Joonho Choe; Taegun Seo
Journal:  Biochem Biophys Res Commun       Date:  2010-03-18       Impact factor: 3.575

8.  Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Seung Min Yoo; Jian-Ping Xie; Philip J Browning; Shou-Jiang Gao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.

Authors:  Alexandre Mercier; Carolina Arias; Alexis S Madrid; Meghan M Holdorf; Don Ganem
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

Authors:  Pei-Ching Chang; Yoshihiro Izumiya; Chun-Yi Wu; Latricia D Fitzgerald; Mel Campbell; Thomas J Ellison; Kit S Lam; Paul A Luciw; Hsing-Jien Kung
Journal:  J Biol Chem       Date:  2009-12-24       Impact factor: 5.157

View more
  9 in total

1.  Sumoylation of the Carboxy-Terminal of Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Attenuates Viral DNA Replication.

Authors:  Jun Chen; Guanlie Li; Haiqing He; Xin Li; Wenjing Niu; Di Cao; Ao Shen
Journal:  Front Microbiol       Date:  2021-04-21       Impact factor: 5.640

Review 2.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

3.  NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.

Authors:  Fang Zhang; Deguang Liang; Xiaoxi Lin; Zhe Zou; Rui Sun; Xing Wang; Xiaozhen Liang; Kenneth M Kaye; Ke Lan
Journal:  PLoS Pathog       Date:  2019-02-27       Impact factor: 6.823

4.  Host RAB11FIP5 protein inhibits the release of Kaposi's sarcoma-associated herpesvirus particles by promoting lysosomal degradation of ORF45.

Authors:  Xiaoqin Wei; Jiazhen Dong; Chin-Chen Cheng; Mingjun Ji; Lei Yu; Shengqiu Luo; Shuwen Wu; Lei Bai; Ke Lan
Journal:  PLoS Pathog       Date:  2020-12-14       Impact factor: 6.823

5.  Inhibition of SENP6 restrains cerebral ischemia-reperfusion injury by regulating Annexin-A1 nuclear translocation-associated neuronal apoptosis.

Authors:  Qian Xia; Meng Mao; Zhen Zeng; Zhenzhao Luo; Yin Zhao; Jing Shi; Xing Li
Journal:  Theranostics       Date:  2021-06-01       Impact factor: 11.556

6.  NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.

Authors:  Xiaoqin Wei; Lei Bai; Lianghui Dong; Huimei Liu; Peidong Xing; Zhiyao Zhou; Shuwen Wu; Ke Lan
Journal:  PLoS Pathog       Date:  2019-11-21       Impact factor: 6.823

7.  Brd/BET Proteins Influence the Genome-Wide Localization of the Kaposi's Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus Major Latency Proteins.

Authors:  Rishikesh Lotke; Ulrike Schneeweiß; Marcel Pietrek; Thomas Günther; Adam Grundhoff; Magdalena Weidner-Glunde; Thomas F Schulz
Journal:  Front Microbiol       Date:  2020-10-22       Impact factor: 5.640

Review 8.  Regulation of KSHV Latency and Lytic Reactivation.

Authors:  Grant Broussard; Blossom Damania
Journal:  Viruses       Date:  2020-09-17       Impact factor: 5.048

Review 9.  SUMO and SUMOylation Pathway at the Forefront of Host Immune Response.

Authors:  Sajeev T K; Garima Joshi; Pooja Arya; Vibhuti Mahajan; Akanksha Chaturvedi; Ram Kumar Mishra
Journal:  Front Cell Dev Biol       Date:  2021-07-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.